iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Medplus Health Services Shares Rise 3% Despite Subsidiary's Drug License Suspension

19 Mar 2024 , 10:33 AM

Medplus Health Services shares rise by 3% in early trade on February 26, despite a subsidiary receiving a suspension order from Drugs and Control Authorities of Mahabubnagar, Telangana. At the time of writing, Medplus Health Services is trading at ₹702.95, up 2.30%, on the BSE.

The assistant director of Drugs Control Administration, Mahabubnagar, Telangana, issued a temporary nine-day suspension of drug license to a store in Wanaparthy, Mahabubnagar.

The company received the suspension order on February 23, estimating a potential revenue loss of ₹1.63 Lakh. Earlier this month, the Thane Food and Drug Administration suspended the drug license for the store in Khopat Thane for 15 days for violating various conditions.

In January, the company received suspension orders for six days for the store at Shankarayapally Jadcherla and seven days for a store at Hayath Nagar, both from the assistant director and drug sales licensing authority of the Drug Control Administration, Mahabubnagar TS.

The company reported a 2.4% rise in net profit at ₹13.73 Crore in the quarter ended December 2023. Medplus Health Services' stock touched a 52-week high of ₹977.45 and a 52-week low of ₹597.95 on July 31, 2023, and February 14, 2024, respectively. Currently, the stock is trading 27.35% below its 52-week high and 18.76% above its 52-week low.

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • Drug License Suspension
  • Medplus Health Services
  • news
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

closeIcon

Get better recommendations & make better investments

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp